The 5th U-PGx Personalized Medicine Day was successfully co-organized by the Golden Helix Foundation and the University of Liverpool, both partners of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353). The Ubiquitous Pharmacogenomics (U-PGx) project aims to promote the clinical application of pharmacogenomics knowledge which will result in less ‘trial and error’ prescribing more efficacious, safer and cost-effective drug therapy. The personalized medicine model is conduct at a large scale in seven existing European health care environments in the Netherlands, Spain, UK, Italy, Austria, Slovenia and Greece.
The active participation of the attendees as well as the presentations by acknowledged professors and scientists in the Genomic Medicine and Pharmacogenomics fields, informed and enlightened the audience. The scientific programme included presentations on the recent results that have been derived from Genomics Programmes such as the 100,000 Genomes Project or the Ubiquitous Pharmacogenomics. Other issues discussed covered the Education, Health Economics and pharmacogenomics. The meeting took place on 21 September 2018 at Liverpool, UK, at the Royal Liverpool Hospital postgraduate Medical Centre lecture theatre.
We would like to kindly thank the following speakers for honoring us with their presence and for their contribution on the meeting success:
Mark Caulfield (London, UK )
Jesse Swen (Leiden, NL)
Sarah Wordsworth (Oxford, UK)
Dyfrig Hughes (North Wales,UK)
Erika Cecchin (Aviano, IT)
Vera Deneer (Utrecht, NL)
Richard Turner (Liverpool, UK)
Sir. Munir Pirmohamed (Liverpool, UK)
The ‘5th U-PGx Personalized Medicine Day’ was open for clinical pharmacologists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.